Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 35 non-cytoplasmic 36 55 transmembrane 56 61 cytoplasmic 62 80 transmembrane 81 91 non-cytoplasmic 92 111 transmembrane 112 122 cytoplasmic 123 143 transmembrane 144 161 non-cytoplasmic 162 182 transmembrane 183 192 cytoplasmic 193 209 transmembrane 210 241 non-cytoplasmic 242 262 transmembrane 263 294 cytoplasmic 295 316 transmembrane 317 328 non-cytoplasmic 329 357 transmembrane 358 361 cytoplasmic 362 380 transmembrane 381 391 non-cytoplasmic 392 409 transmembrane 410 423 cytoplasmic
Input: >WP_043531483.1 NCBI__GCF_000759345.1:WP_043531483.1 MNRTLPVRETVLFSGLLVAVVLIYLSMGSAYSTRMLVEAACYAILALGLTIQWGYAGQFN AGVMGFVALGGFAAMFFSVPTNPDFWNTDLPGQLGIVLLMLVVSIALVFVASRLDRVGLP KRLRTIVTVVLALVLYLVVISALREVTGEIESQAGFIGGLGLPAWTGWIVGGALAGGLGY FIGHICLGLRSDYLAIATLGIAEIIKAFLKNSDWLTRGTATVSPLPWPTPGPSELGFTLS RALYLSITAVLIAVIFFLLHRAYHAPWGRMIRAIRDNEVSAAAMGKDINRRRLEIFVLGC ILMGIGGAVLTSFNGLFDPQGYLPLNHTFLVLVMVILGGPGNNLGTIFGAVLVYIIWIMS EPLALFLMQGAVTLGEAWFGWDAPSNLDSRALQARVFVIGLLISLVLRYEPKGLIPEKVP EHD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server